BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 18790456)

  • 1. Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation.
    Williams KM; Gress RE
    Best Pract Res Clin Haematol; 2008 Sep; 21(3):579-96. PubMed ID: 18790456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease.
    Chang YJ; Zhao XY; Huang XJ
    Front Immunol; 2018; 9():3041. PubMed ID: 30619371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to enhance the graft-versus-malignancy effect in allogeneic transplants.
    Barrett JA
    Ann N Y Acad Sci; 1995 Dec; 770():203-12. PubMed ID: 8597361
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of low-dose anti-thymocyte globulin on immune reconstitution after allogeneic hematopoietic cell transplantation.
    Ito A; Kitano S; Tajima K; Kim Y; Tanaka T; Inamoto Y; Kim SW; Yamamoto N; Fukuda T; Okamoto S
    Int J Hematol; 2020 Jan; 111(1):120-130. PubMed ID: 31641956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients.
    Maury S; Mary JY; Rabian C; Schwarzinger M; Toubert A; Scieux C; Carmagnat M; Esperou H; Ribaud P; Devergie A; Guardiola P; Vexiau P; Charron D; Gluckman E; Socié G
    Br J Haematol; 2001 Dec; 115(3):630-41. PubMed ID: 11736948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
    Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
    Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New strategies in allogeneic stem cell transplantation: immunotherapy using irradiated allogeneic T cells.
    Waller EK; Boyer M
    Bone Marrow Transplant; 2000 May; 25 Suppl 2():S20-4. PubMed ID: 10933181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection.
    Mehta RS; Rezvani K
    Virulence; 2016 Nov; 7(8):901-916. PubMed ID: 27385018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Pre-Transplant Anti-T Cell Globulin (ATG) on Immune Recovery after Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation.
    Servais S; Menten-Dedoyart C; Beguin Y; Seidel L; Gothot A; Daulne C; Willems E; Delens L; Humblet-Baron S; Hannon M; Baron F
    PLoS One; 2015; 10(6):e0130026. PubMed ID: 26098781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune reconstitution following hematopoietic stem-cell transplantation.
    Novitzky N; Davison GM
    Cytotherapy; 2001; 3(3):211-20. PubMed ID: 12171728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunity.
    Bunting MD; Varelias A; Souza-Fonseca-Guimaraes F; Schuster IS; Lineburg KE; Kuns RD; Fleming P; Locke KR; Huntington ND; Blazar BR; Lane SW; Tey SK; MacDonald KP; Smyth MJ; Degli-Esposti MA; Hill GR
    Blood; 2017 Feb; 129(5):630-642. PubMed ID: 27927647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regeneration of the immune system after bone marrow transplantation].
    Uher F; Puskás E; Torbágyi E; Barta A; Kormos L; Pálóczi K
    Orv Hetil; 2001 Jan; 142(2):59-65. PubMed ID: 11209506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency analysis of TRBV subfamily sjTRECs to characterize T-cell reconstitution in acute leukemia patients after allogeneic hematopoietic stem cell transplantation.
    Wu X; Zhu K; Du X; Chen S; Yang L; Wu J; Liu Q; Li Y
    J Hematol Oncol; 2011 Apr; 4():19. PubMed ID: 21513557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Allogeneic haematopoietic stem cell transplantation - an overview].
    Holtick U; Chemnitz JM; Hallek M; Scheid C
    Klin Monbl Augenheilkd; 2015 May; 232(5):641-6. PubMed ID: 25989032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative depletion of α/β+ T cells and of CD19+ B lymphocytes: a novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation.
    Locatelli F; Bauquet A; Palumbo G; Moretta F; Bertaina A
    Immunol Lett; 2013; 155(1-2):21-3. PubMed ID: 24091162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the thymus in allogeneic hematopoietic stem cell transplantation.
    Krenger W; Holländer GA
    Swiss Med Wkly; 2010; 140():w13051. PubMed ID: 20648397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.
    Hamadani M; Zhang MJ; Tang XY; Fei M; Brunstein C; Chhabra S; D'Souza A; Milano F; Phelan R; Saber W; Shaw BE; Weisdorf D; Devine SM; Horowitz MM
    Biol Blood Marrow Transplant; 2020 Jul; 26(7):1312-1317. PubMed ID: 32283185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune recovery after in vivo T-cell depletion myeloablative conditioning hematopoietic stem cell transplantation in severe beta-thalassemia children.
    Qin F; Shi L; Li Q; Zhang Z; Liu L; Li J; Yang G; Lai YR
    Eur J Haematol; 2019 Oct; 103(4):342-350. PubMed ID: 31276236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.